Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-06-27Clinical Trial Update: First-line Treatment of Patients With Stage IV Nonsquamous Non-Small Cell Lung Cancer With Necitumumab (IMC-11F8) and Pemetrexed-Cisplatin [Phase 3]
Phase 3 trial update for first-line treatment of stage IV nonsquamous non-small cell lung cancer using necitumumab with pemetrexed-cisplatin…
-
CLINICAL_TRIALS trial_result · 2016-06-23Clinical Trial Update: Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Versus Placebo in Addition to Paclitaxel and Carboplatin [Phase 3]
Phase 3 trial evaluating ipilimumab plus paclitaxel and carboplatin versus placebo in squamous non-small cell lung cancer; study completed w…
-
CLINICAL_TRIALS trial_result · 2016-06-23Clinical Trial Update: Iressa Follow-up Trial [Phase 3]
Phase 3 follow-up trial of Iressa (gefitinib) in non-small cell lung cancer and breast cancer has completed, with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-06-22Clinical Trial Update: Study to Assess the Effect of AZD9291 on the Blood Levels of Simvastatin in Patients With EGFRm+ NSCLC [Phase 1]
This Phase 1 trial assessed whether AZD9291 (osimertinib) alters the blood levels of simvastatin in patients with EGFR mutation-positive non…
-
CLINICAL_TRIALS trial_result · 2016-06-22Clinical Trial Update: Docetaxel With or Without Low-dose, Short Course Sunitinib in Refractory Solid Tumors [Phase 2]
Phase 2 trial update evaluating docetaxel with or without low-dose, short-course sunitinib in refractory solid tumors, including breast canc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-06-16Clinical Trial Update: Pemetrexed Plus Cisplatin Versus Gemcitabine Plus Cisplatin for Advanced NSCLC Metastatic Non-small Cell Lung Cancer [Phase 2]
A Phase 2 randomized trial compared pemetrexed plus cisplatin versus gemcitabine plus cisplatin in advanced/metastatic non-small cell lung c…
-
CLINICAL_TRIALS trial_result · 2016-06-14Clinical Trial Update: A Study of AMG 951 [rhApo2L/TRAIL] in Subjects With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) Treated With Chemotherapy +/- Bevacizumab [Phase 2]
A Phase 2 clinical trial evaluating AMG 951 (rhApo2L/TRAIL) in previously untreated non-small cell lung cancer patients treated with chemoth…
-
CLINICAL_TRIALS trial_result · 2016-06-14Clinical Trial Update: A Placebo Controlled Study Comparing AZD1775+ Docetaxel Versus Placebo+Docetaxel to Treat Lung Cancer [Phase 2]
A Phase 2 randomized trial comparing AZD1775 plus docetaxel versus placebo plus docetaxel in previously treated non-small cell lung cancer w…
-
CLINICAL_TRIALS trial_result · 2016-06-09Clinical Trial Update: An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene [Phase 2]
A Phase 2 clinical trial evaluating PF-02341066 (crizotinib) in patients with advanced non-small cell lung cancer with ALK gene alterations …
-
CLINICAL_TRIALS trial_result · 2016-06-09Clinical Trial Update: Tolerability and Efficacy of Tremelimumab in Combination With Gefitinib in NSCLC Patients [Phase 1]
This Phase 1 trial update reports tolerability and early efficacy data for the combination of tremelimumab with gefitinib in non-small cell …
-
CLINICAL_TRIALS trial_result · 2016-06-07Clinical Trial Update: Phase II AZD9291 Open Label Study in NSCLC After Previous EGFR TKI Therapy in EGFR and T790M Mutation Positive Tumours [Phase 2]
Phase II open-label study of AZD9291 (osimertinib) in EGFR-mutant, T790M-positive non-small cell lung cancer after progression on prior EGFR…
-
CLINICAL_TRIALS trial_result · 2016-06-06Clinical Trial Update: Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating nab-paclitaxel in combination with carboplatin for stage IIIB/IV or recurrent non-small cell lung cancer has comple…
-
CLINICAL_TRIALS trial_result · 2016-06-03Clinical Trial Update: Phase 1b/2 Trial of AMG386 With Pemetrexed and Carboplatin in Non-Small Cell Lung Cancer [Phase 1, Phase 2]
Phase 1b/2 trial update of AMG-386 with pemetrexed and carboplatin in non-small cell lung cancer has completed the indicated phases.
-
CLINICAL_TRIALS trial_result · 2016-06-02Clinical Trial Update: Iressa v BSC (Best Supportive Care) in First Line NSCLC [Phase 2, Phase 3]
Phase 2 and Phase 3 trials comparing Iressa (gefitinib) to Best Supportive Care in first-line non-small cell lung cancer have been completed…
-
CLINICAL_TRIALS trial_result · 2016-06-02Clinical Trial Update: Pemetrexed Plus Cetuximab in Patients With Recurrent Non Small Cell Lung Cancer [Phase 1, Phase 2]
The update reports the completion of a Phase 1/2 study evaluating the combination of pemetrexed with cetuximab in patients with recurrent no…
-
CLINICAL_TRIALS trial_result · 2016-06-01Clinical Trial Update: Dacomitinib (PF-00299804) As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung [Phase 2]
Phase 2 clinical trial updating Dacomitinib (PF-00299804) as a single oral agent in selected patients with non-small cell lung adenocarcinom…
-
CLINICAL_TRIALS trial_result · 2016-06-01Clinical Trial Update: Influence of the Use of the Diabetic Drug Metformin on the Overall Survival and Treatment-related Toxicity in Advanced Stage Non-small Cell Lung Cancer Patients.
A completed clinical trial evaluated whether metformin use influences overall survival and treatment-related toxicity in patients with advan…
-
CLINICAL_TRIALS trial_result · 2016-05-26Clinical Trial Update: A Study of Alectinib (RO5424802) in Participants With Non-Small Cell Lung Cancer Who Have Anaplastic Lymphoma Kinase (ALK) Mutation and Failed Crizotinib Treatment [Phase 1, Phase 2]
Phase 1/2 study of alectinib in ALK-positive NSCLC patients who failed crizotinib; trial completed with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-05-25Clinical Trial Update: SORAVE - Sorafenib and Everolimus in Solid Tumors [Phase 1]
A Phase 1 trial evaluating sorafenib and everolimus in solid tumors, including non-small cell lung cancer, has completed.
-
CLINICAL_TRIALS trial_result · 2016-05-24Clinical Trial Update: D-CIK Combined With Chemotherapy for Non-Small Cell Lung Cancer(NSCLC) [Phase 1, Phase 2]
This document summarizes a Phase 1/2 clinical trial evaluating D-CIK cells combined with chemotherapy for non-small cell lung cancer, with t…
-
CLINICAL_TRIALS trial_result · 2016-05-23Clinical Trial Update: A Study of Metronidazole Cream in the Prevention and Treatment of Tarceva (Erlotinib)-Associated Rash [Phase 2]
Phase 2 trial evaluating metronidazole cream to prevent or treat erlotinib-associated rash in patients with non-squamous non-small cell lung…
-
CLINICAL_TRIALS trial_result · 2016-05-20Clinical Trial Update: Molecular Imaging With Erlotinib and Bevacizumab [Phase 2]
Phase 2 clinical trial update evaluating molecular imaging with erlotinib and bevacizumab in non-small cell lung cancer. The study status is…
-
CLINICAL_TRIALS trial_result · 2016-05-19Clinical Trial Update: A Study of First Line Treatment With Tarceva (Erlotinib) in Combination With Gemcitabine in Patients With Unresectable Advanced and/or Metastatic Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating first-line erlotinib (Tarceva) in combination with gemcitabine for unresectable advanced/metastatic non-small cell …
-
CLINICAL_TRIALS trial_result · 2016-05-17Clinical Trial Update: Study to Evaluate KOS-1584 in Patients With Advanced or Metastatic Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
A Phase 2 study evaluating KOS-1584 in advanced or metastatic non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-05-13Clinical Trial Update: Docetaxel Combined With Cisplatin as First Line in Patients With Metastatic Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating first-line docetaxel plus cisplatin for metastatic non-small cell lung cancer has been suspended.